AAT 076
Alternative Names: AAT-076; RMX 1001; RQ-00317076Latest Information Update: 28 Jul 2025
At a glance
- Originator RaQualia Pharma
- Developer AskAt; HaiHe Biopharma; RaQualia Pharma
- Class Analgesics; Small molecules
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase II Acute pain
- No development reported Neuropathic pain; Postoperative pain
Most Recent Events
- 28 Jul 2025 No recent reports of development identified for phase-I development in Neuropathic-pain in China
- 28 Jul 2025 No recent reports of development identified for preclinical development in Neuropathic-pain in Japan
- 05 Aug 2024 Efficacy data from preclinical studies in Neuropathic pain presented at World Congress on Pain (WCP-2024)